3
Announcements
Trials
Browse
Landscape
Status
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
4
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
1
Conditions
Neoplasms
1
Hematologic Neoplasms
1
Cardiovascular Diseases
1
Interventions
Blood Specimen Collection
19
Surveys and Questionnaires
18
Specimen Handling
16
Radiotherapy
7
Magnetic Resonance Spectroscopy
7
Surgical Procedures, Operative
6
trastuzumab deruxtecan
5
Observation
5
Data Collection
5
darolutamide
4
Patient Reported Outcome Measures
4
Magnetic Resonance Imaging
4
Cryosurgery
4
Breath Tests
4
Biopsy
4
ribociclib
3
atezolizumab
3
Watchful Waiting
3
Ultrasonography
3
Tomography, X-Ray Computed
3
Standard of Care
3
Radiation
3
Mental Status and Dementia Tests
3
Letrozole
3
Interviews as Topic
3
Immune Checkpoint Inhibitors
3
Hepatectomy
3
Bevacizumab
3
palbociclib
2
lorlatinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Antineoplastic Agents
×
30 days
×
Clear all
NCT07621289
2026-06-02
EUCARTOXSCORES
University Hospital, Caen
Not yet recruiting
10,000 enrolled